Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

News headlines Recursion Pharmaceuticals reported mixed Q2 results, with revenue falling to $7.67 million but narrowing net losses. The company highlighted significant clinical milestones, including ...

Fox News is an independent company that does not claim any ownership of the term "Word Search". "Word Search" is only used for descriptive purposes and we do not claim any official association with ...